Common blood thinners reduce serious events by 69% in atrial fibrillation patients

The randomized SINGLE-AF trial found that direct oral anticoagulants reduce the risk of serious clinical events by 69% in atrial fibrillation patients with an intermediate stroke risk. This significant benefit was primarily due to fewer ischemic strokes and occurred without an increase in major bleeding.

Originally published by gnews